Concentration On Your Terms: Setting Final Volume To Fit The Process
A concentration step is usually judged by recovery and viability. Final volume gets less scrutiny, though it sets the concentration that dosing, cryoprotectant introduction, or the next unit operation has to work with. On many systems that volume is fixed by the equipment rather than defined by the process.
The consequences show up as programs approach the clinic and targets tighten. Source material varies by patient in autologous work and by donor in allogeneic work, and expansion yields shift from run to run, so the volume needed to hit a given concentration does not stay put. Teams that can't reach it in one step have familiar options: a second system, manual finishing at the bench, or a more dilute product passed downstream. Each adds handling, time, and variability at the point where the cells are most concentrated and most valuable.
The argument here is that final volume belongs with the critical process parameters: defined, controlled by recipe, and adjusted per run. The perspective centers on closed, low-shear continuous centrifugation. Read the Insights article for the full argument.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.